A.R.T. Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

A.R.T. Advisors’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-71,140	Closed	-$433K	–	1893
2019 Q2	$433K	Buy	+71,140	New	+$378K	0.02%	803
2019 Q1	–	Sell	-60,321	Closed	-$812K	–	1778
2018 Q4	$812K	Buy	+60,321	New	+$1.02M	0.05%	523
2018 Q1	–	Sell	-104,020	Closed	-$2.09M	–	1894
2017 Q4	$2.09M	Buy	104,020 +85,590	+464%	+$1.68M	0.09%	357
2017 Q3	$381K	Sell	18,430 -36,011	-66%	-$609K	0.02%	922
2017 Q2	$805K	Sell	54,441 -210,080	-79%	-$3.5M	0.04%	610
2017 Q1	$4.22M	Buy	264,521 +80,121	+43%	+$1.16M	0.19%	133
2016 Q4	$2.32M	Buy	184,400 +162,600	+746%	+$3.03M	0.14%	220
2016 Q3	$610K	Buy	+21,800	New	+$732K	0.2%	157
2015 Q3	–	Sell	-16,849	Closed	-$753K	–	1727
2015 Q2	$753K	Sell	16,849 -22,074	-57%	-$830K	0.03%	829
2015 Q1	$1.34M	Buy	38,923 +18,469	+90%	+$503K	0.05%	551
2014 Q4	$560K	Buy	+20,454	New	+$496K	0.02%	887

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

A.R.T. Advisors's DPLO Position: Q3 2019 in Review

A.R.T. Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2019, closing a stake of 71,140 shares — an estimated $433K sold.

A.R.T. Advisors first reported a position in DPLO in Q4 2014 and held it in 11 quarters. The position peaked at $4.22M in Q1 2017. 137 funds tracked by Wall St. Rank hold DPLO as of Q3 2019.

A.R.T. Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2019 after selling out during the quarter.
A.R.T. Advisors sold 71,140 DIPLOMAT PHARMACY, INC. shares in Q3 2019, an estimated $433K.
A.R.T. Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 11 quarters.
A.R.T. Advisors's DIPLOMAT PHARMACY, INC. position peaked at $4.22M in Q1 2017.
137 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2019.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.